This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Eero Mäntylä: Innovator in Pharmaceutical Compositions
Introduction
Eero Mäntylä is a notable inventor based in Piispanristi, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in lowering serum cholesterol.
Latest Patents
Eero Mäntylä holds a patent for E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof. This invention is particularly useful in lowering serum cholesterol and includes methods for the prevention and treatment of atherosclerosis. His innovative approach addresses critical health issues related to cardiovascular diseases.
Career Highlights
Eero is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work has contributed to advancements in medical treatments and has the potential to improve patient outcomes significantly.
Collaborations
Eero has collaborated with several professionals in his field, including Marja-Liisa Södervall and Arja Marketta Kalapudas. These collaborations have likely enhanced the research and development processes within his projects.
Conclusion
Eero Mäntylä's contributions to pharmaceutical innovations demonstrate his commitment to improving health through science. His patent reflects a significant step forward in the treatment of cholesterol-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile